Cargando…
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors
Tyrosine kinase inhibitors (TKIs) have improved the overall survival of patients with gastrointestinal stromal tumors (GISTs), but their side effects can impact dose intensity and, consequently, the clinical benefit. To date, no guideline or consensus has been published on the TKI-associated adverse...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295840/ https://www.ncbi.nlm.nih.gov/pubmed/30581268 http://dx.doi.org/10.3748/wjg.v24.i46.5189 |